The downregulation of OCT2 has been documented in both rat and mouse models of chronic kidney disease (CKD) or acute kidney injury (AKI), as well as in human patients with CKD, primarily attributed to inflammatory processes and oxidative stress [50]. This evidence concerns the gene SLC22A2 and chronic kidney disease.